CausalSentinel

Protein Dossier — GHR (Growth hormone receptor)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Birth weight -0.0498 0.033 0.131 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0543 0.0386 0.16 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0744 0.0699 0.287 Wald ratio 1 cis NA
Low grade serous ovarian cancer 0.238 0.294 0.418 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0313 0.0459 0.495 Wald ratio 1 cis NA

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2948_58_2 Growth hormone receptor Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

140 association rows across 60 traits (122 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Height 1e-300 rs2910875 29 GCST90245848 no MR -> candidate analysis
GHR protein levels 1e-298 rs55730643 16 GCST90469342 no MR -> candidate analysis
Height (maximum, inv-normal transformed) 2e-120 rs55681913 2 GCST90475359 no MR -> candidate analysis
IGF 1 (UKB data field 30770) 3e-71 rs55681913 2 GCST90468078 no MR -> candidate analysis
What is your height? (cm, inv-normal transformed) 4e-66 rs55681913 2 GCST90475368 no MR -> candidate analysis
Growth hormone receptor levels 1e-65 rs10440652 4 GCST90247729 no MR -> candidate analysis
Standing height (UKB data field 50) 2e-51 rs55681913 2 GCST90468178 no MR -> candidate analysis
SELENOP protein levels 1e-45 rs4315928 1 GCST90470565 no MR -> candidate analysis
Height (baseline) 9e-44 rs55681913 8 GCST90565843 no MR -> candidate analysis
Appendicular lean mass 8e-40 rs62372052 2 GCST90000025 no MR -> candidate analysis
Whole body water mass (UKB data field 23102) 5e-38 rs62372052 2 GCST90468184 no MR -> candidate analysis
Body shape phenotype PC2 2e-35 rs62372052 2 GCST90832990 no MR -> candidate analysis
…and 48 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1358 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Laron syndrome 0.919 established (curated) no MR -> candidate analysis
short stature due to partial GHR deficiency 0.828 established (curated) no MR -> candidate analysis
growth hormone insensitivity syndrome 0.835 established (curated) no MR -> candidate analysis
Short stature 0.559 established (curated) no MR -> candidate analysis
hypercholesterolemia, familial, 1 0.81 established (curated) no MR -> candidate analysis
Abnormality of the skeletal system 0.81 common-variant locus no MR -> candidate analysis
atrial fibrillation 0.79 common-variant locus no MR -> candidate analysis
obesity disorder 0.546 common-variant locus no MR -> candidate analysis
short stature due to GHSR deficiency 0.525 established (curated) no MR -> candidate analysis

Of the 9 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 6 known modulators (Growth hormone receptor)
gnomAD constraint pLI=4e-05, LOEUF=0.692 — LoF-tolerant
GWAS Catalog 102 unique SNPs / 208 rows
ClinVar 681 records; 11 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance